recombinant human granulocyte colony-stimulating factor (rhu g-csf; filgrastim) (Amgen)
90
Structured Review
Amgen
recombinant human granulocyte colony-stimulating factor (rhu g-csf; filgrastim)
Recombinant Human Granulocyte Colony Stimulating Factor (Rhu G Csf; Filgrastim), supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhu/recombinant+human+g+csf/pm40074513-40-15-18
Average 90 stars, based on 1 article reviews
Recombinant Human Granulocyte Colony Stimulating Factor (Rhu G Csf; Filgrastim), supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhu/recombinant+human+g+csf/pm40074513-40-15-18
Average 90 stars, based on 1 article reviews
recombinant human granulocyte colony-stimulating factor (rhu g-csf; filgrastim) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Real World Clinical Experience of Biosimilar G-CSF (Grastofil) for Autologous Peripheral Blood Stem Cell Mobilization: Single Center Experience in Canada Following Early Adoption Article Snippet: Granulocyte colony-stimulating factor (G-CSF) is the first line treatment for mobilization, most commonly using a regimen of daily Article Title: Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Article Snippet: Clonogenic and Long Term Culture (LTC) Assays Clonogenic progenitors from human fresh CB cells were assayed in 0.8% methylcellulose containing 30% FCS, 1% deionized BSA, and 10-4M 2-mercaptoethanol, in the presence of 50 ng/mlrhu-SCF, 10 ng/ml Article Title: In Vivo Mobilization and Functional Characterization of Non-Human Primate Monocytic Myeloid-Derived Suppressor Cells Article Snippet: Prior to leukapheresis, monkeys received recombinant human (rhu) GM-CSF (Leukine; Genzyme, Cambridge, MA; 10μg/kg/day for 4 days), followed by Article Title: Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation Article Snippet: Prior to leukapheresis, monkeys received recombinant human (rhu) granulocyte-macrophage (GM)-colony-stimulating factor (CSF) (Leukine; Genzyme, Cambridge, MA; 10μg/kg/day for 4 days), followed by Article Title: Enhanced Collection of Phenotypic and Engrafting Human Cord Blood Hematopoietic Stem Cells at 4°C Article Snippet: 14 Human CB HPC by colony assay Immediately following one hour acclimation to RT or 4°C, 5×10 4 human CB mononuclear cells were plated in 1 ml of colony assay media containing Iscove’s Modified Dulbecco’s Medium (IMDM, Lonza), 1% methylcellulose, 30% fetal bovine serum (FBS, Hyclone), 50 ng recombinant human (rhu) stem cell factor (SCF, R&D Systems), 10 ng rhu granulocyte-macrophage-colony stimulating factor (GM-CSF, R&D Systems), 10 ng rhu interleukin 3 (IL-3, R&D Systems), 1 unit Article Title: Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation Article Snippet: Hematopoietic growth factor mobilization and leukapheresis Prior to leukapheresis, monkeys received recombinant human (rhu) granulocyte-macrophage (GM)-colony-stimulating factor (CSF) (Leukine; Genzyme, Cambridge, MA; 10μg/kg/day for 4 days), followed by Recombinant:Article Title: Cytokine therapy of acute radiation syndrome. Article Snippet: Radiological accidents/incidents are common with nearly 400 reported since 1944 exposing about 3000 people to substantial doses of ionizing radiations with 127 deaths.. Damage to hematopoietic stem and progenitor cells with resulting bone marrow failure is a common consequence of exposure to whole body acute high-dose and -dose-rate ionizing radiations and is termed hematopoietic-acute radiation syndrome, or H-ARS.. Therapy of H-ARS includes transfusions, anti-bacterial and -viral drugs, molecularly-cloned hematopoietic growth factors and hematopoietic cell transplants. Article Title: Sargramostim in acute radiation syndrome. Article Snippet: Three molecularly cloned hematopoietic growth factors are US FDA-approved to increase survival in adult and pediatric patients acutely exposed to myelosuppressive doses of radiation (hematopoietic syndrome of acute radiation syndrome, or ‘H-ARS’ [21–23]) and accelerate bone marrow recovery after exposure to acute, high-dose, and high-dose-rate ionizing radiation in accidents and other settings. .. These include |
